🩻 Diagnostic Imaging 📡 Computed tomography (CT) with IV contrast — pulmonary angiography protocol

CT Pulmonary Angiography (CTPA): Nursing Guide

CT pulmonary angiography is the cross-sectional study nurses coordinate when pulmonary embolism is suspected after clinical probability tools and D-dimer results. Focus on IV contrast and renal screening, pregnancy assessment, patent IV access, safe transport, oxygen titration, and urgent action when preliminary reads report emboli or symptoms worsen despite pending formal reports.

14 min read
Updated June 20, 2026
Medically Reviewed

Quick Facts

Category
Diagnostic imaging
Why it is ordered
Evaluate acute dyspnea
Main nursing risk
Transport before contrast/renal clarification
Turnaround
Preliminary reads often same shift

Key Takeaway

The main nursing priority with CTPA is verifying the PE indication, screening IV iodinated contrast allergy and kidney function per protocol, maintaining oxygen and monitoring during transport, and escalating when preliminary emboli.

Imaging Parameters & Safety

Nurse quick-reference for imaging prep, safety screening, and transport.

Radiation ⚠️ Ionising radiation used
Modality

Computed tomography (CT) with IV contrast — pulmonary angiography protocol

Contrast required

IV iodinated contrast required for standard CTPA pulmonary angiography protocols

Radiation exposure

Uses ionising radiation; dose is protocol- and equipment-dependent — not specified as a universal value in the published references

Duration

Breath-hold acquisition often seconds; total visit longer with contrast screening, IV placement, and monitored transport

Patient position

Supine on the CT table with arms elevated; breath-hold coaching during pulmonary artery phase acquisition per radiology protocol

Fasting / prep

NPO for several hours may be required when IV contrast is used — follow radiology order and local policy

What is CT Pulmonary Angiography (CTPA)?

CT Pulmonary Angiography (CTPA) is a computed tomography study that uses IV iodinated contrast timed to opacify the pulmonary arteries so radiologists can identify filling defects consistent with pulmonary embolism. It is performed in radiology or emergency imaging departments when clinical probability, D-dimer, and often chest radiograph findings suggest PE as the leading diagnosis.

Overview

Nurses on emergency, medical-surgical, and critical care units coordinate CTPA when patients present with shortness of breath, pleuritic chest pain, or hemoptysis and clinicians suspect pulmonary embolism or deep vein thrombosis with embolization. Ward nurses do not operate the scanner but are essential for identification, contrast and renal screening, IV access, pregnancy assessment, transport, post-contrast monitoring, and communicating urgent preliminary reads.

Because PE can cause rapid hypoxemia and hemodynamic compromise, delays in safety screening or transport can affect time to anticoagulation or advanced therapy. At the same time, a negative or indeterminate CTPA does not eliminate PE in every clinical context — integrate results with examination, arterial blood gas trends when ordered, and ongoing oxygen therapy. ESC and national clinical guidelines VTE guidance emphasize matching imaging to pre-test probability rather than treating any single study as the final answer.

Clinical Nursing Focus

Before CTPA, verify contrast allergy history, pregnancy status when relevant, and renal function per institutional protocol when IV iodinated contrast is ordered. After the scan, monitor for contrast reactions and escalate new respiratory distress, hypotension, or positive preliminary PE reports according to facility policy — do not defer anticoagulation pathways while waiting for formal wording if the clinical picture and preliminary read align.

IV Contrast, Radiation, and PE Pathway Safety

CTPA is time-sensitive in suspected pulmonary embolism, but iodinated contrast and outdated renal screening create avoidable harm. Treat falling SpO₂, unclear allergy history, and positive preliminary emboli as clinical priorities — not tasks to defer until a formal report arrives.

Highest-risk scenarios
  • Transport to CT before IV contrast allergy and renal function are clarified per protocol
  • Preliminary pulmonary emboli with hypoxemia, tachycardia, or hypotension
  • Marked deterioration despite negative or pending CTPA while clinical probability remains high
  • Suspected contrast anaphylaxis — airway swelling, wheeze, or hypotension after injection

Document: contrast and renal screening, transport time, baseline and trend SpO₂, preliminary read communication, anticoagulation orders, and patient teaching.

What CTPA Can and Cannot Tell You

This test can help identify:

  • Filling defects consistent with acute pulmonary embolism in segmental or larger arteries
  • Central clot burden and some right-heart strain patterns when reported on formal reads
  • Alternate thoracic diagnoses when PE is excluded and another cause explains symptoms
  • Need for urgent anticoagulation, ICU monitoring, or advanced PE therapy pathways

This test cannot:

  • Replace clinical probability assessment, D-dimer interpretation, or bedside monitoring
  • Exclude every PE in all high-probability contexts — guideline pathways may require further testing
  • Diagnose deep vein thrombosis without separate venous imaging when leg thrombosis is suspected
  • Determine treatment alone — results must be integrated with examination and trends

Pre-scan Safety for CTPA and PE Workups

Verify

Correct patient, STAT CTPA order, and PE indication
IV contrast allergy history clarified with radiology when unclear
Recent creatinine or eGFR when institutional policy requires renal screening
Patent IV access and pregnancy screen when radiation policy applies
Baseline SpO₂, vitals, and anticoagulant medicines on MAR documented
Monitored transport plan with oxygen for unstable patients

Clarify before proceeding when:

  • Order does not match symptoms or duplicates recent adequate CTPA without clinical change
  • Allergy history is vague — topical iodine only versus true IV anaphylaxis
  • Creatinine is outdated or AKI is suspected before iodinated contrast
  • Patient cannot lie flat or travel without monitored escort
  • Preliminary read conflicts strongly with examination or D-dimer context
  • Anticoagulation timing relative to scan is unclear — clarify with prescriber

Integrating CTPA Reports With PE Probability

Integrate CTPA reports with pre-test probability, D-dimer, leg examination, SpO₂ trends, heart rate, blood pressure, and anticoagulation response. Negative scans in high-probability patients may still need serial assessment or alternate imaging per ESC and national clinical guidelines VTE pathways.

Clinical contextPair with CTPA findingsNursing focus
High probability + elevated D-dimerEmboli reported or negative preliminaryAnticoagulation pathway, oxygen, bleeding precautions, ICU consult when massive PE suspected
Pleuritic pain + tachycardia + clear CXRPending or indeterminate CTPADo not reassure based on CXR alone — track scan completion and symptoms
Leg swelling + hypoxemiaPE confirmed or DVT workup pendingCoordinate leg ultrasound; teach calf swelling reporting
Negative CTPA + worsening SpO₂Discordant resultEscalate per protocol — repeat imaging, V/Q, or alternate diagnosis workup
↔ On a small screen, swipe or scroll sideways to see the full table.

Contrast Screening, Transport, and Anticoagulation at the Bedside

Bedside pointNursing note
Contrast allergy triageTopical iodine reaction ≠ automatic IV contrast allergy — clarify before transport
Renal labs staleRequest BMP or clarify with prescriber when creatinine is months old
Breath-hold coachingTachypnea and anxiety reduce scan quality — preoxygenate and coach per RT/radiology
False reassuranceNegative preliminary CTPA with falling SpO₂ still requires escalation
Preliminary PE readsDocument verbal/preliminary communication time, recipient, and anticoagulation orders
Evaluate outcomesRepeat SpO₂ and heart rate after anticoagulation — is work of breathing improving?
↔ On a small screen, swipe or scroll sideways to see the full table.

CTPA Across ED, Ward, and ICU Pathways

Diagnostic safety badge: High-acuity imaging — contrast, radiation, and PE pathway checks apply; positive preliminary reads and respiratory deterioration require immediate escalation.

Check-before-test protocol

  1. Identity + PE indication + STAT CTPA with contrast confirmed
  2. Allergy, pregnancy, and renal screening per policy
  3. IV access, baseline SpO₂, and monitored transport plan
  4. Post-contrast monitoring and preliminary read tracking
  5. Anticoagulation and bleeding precaution coordination when PE confirmed

Critical teach-back questions

  • “Can you tell me why this lung artery scan is being done today?”
  • “What symptoms — breathlessness, chest pain, leg swelling — should you report immediately?”
  • “Do you understand we may start blood-thinning medicine quickly if a clot is found?”

Care coordination: prescriber, radiology, respiratory therapy, pharmacy, anticoagulation services, and rapid response teams when ordered.

CTPA Quick Clinical Checklist

  • Is contrast allergy and renal function clarified before iodinated CTPA transport?
  • Does SpO₂ or work of breathing conflict with a negative or pending report?
  • Has a positive preliminary PE read been communicated and anticoagulation initiated per orders?
  • Are leg symptoms and DVT imaging tracked alongside pulmonary results?
  • Did I document contrast screening, oxygen trends, and escalation calls?

Why CT Pulmonary Angiography (CTPA) is Ordered

CTPA is ordered when clinicians need direct visualization of pulmonary arterial filling defects in patients with sufficient clinical probability for PE.

Clinical Indication What the Test Answers Nursing Rationale
Suspected acute pulmonary embolism Are there intraluminal filling defects in segmental or larger pulmonary arteries? Supports anticoagulation, hemodynamic support, and escalation to advanced PE therapies when paired with symptoms, D-dimer, and clinical probability tools per specialty guidelines.
High clinical probability with elevated D-dimer or equivocal initial imaging Does CTPA confirm or exclude PE when CXR and bedside data are inconclusive? Integrates with Wells or institutional PE scores and D-dimer trends — nurses track whether results change anticoagulation and monitoring plans.
Unexplained hypoxemia or pleuritic pain with risk factors for VTE Is embolism the leading diagnosis after initial assessment? Supports VTE pathways linking to DVT evaluation and anticoagulation when PE is confirmed or highly suspected.
Hemodynamic instability or massive PE concern Are central clot burden or right-heart strain patterns reported? Guides ICU monitoring, thrombolysis or embolectomy pathways, and echocardiography correlation when integrated with examination — per institutional PE protocols.
↔ On a small screen, swipe or scroll sideways to see the full table.

Contraindications and Precautions

Absolute contraindications are patient- and protocol-specific. Nurses focus on precautions that require prescriber or radiology clarification before IV contrast CTPA.

When to delay or clarify before CTPA
  • Known anaphylaxis or severe iodinated contrast reaction without a documented premedication or alternate imaging plan.
  • AKI, eGFR below institutional threshold, or outdated creatinine when IV contrast is ordered — clarify with prescriber and radiology per radiology guidelines/NKF guidance.
  • Unstable patient who cannot safely lie flat or travel without monitored escort and oxygen plan.
Pregnancy, radiation, and anticoagulation factors
  • Possible or confirmed pregnancy — risk-benefit discussion and shielding per radiation protection policy when PE cannot wait.
  • Metformin and other medicines may require review around contrast use per local protocol.
  • Recent anticoagulation does not automatically cancel CTPA but affects interpretation timing — document medicines on MAR and clarify hold parameters with prescriber.
Escalate If
  • Preliminary or verbal read reporting pulmonary emboli with hypoxemia, hypotension, or syncope.
  • Marked respiratory distress or falling SpO₂ despite supplemental oxygen while CTPA is pending or after a negative preliminary read.
  • Suspected contrast anaphylaxis — airway swelling, wheeze, hypotension, or respiratory distress during or after injection.

Patient Preparation

CTPA preparation centers on contrast safety, renal screening, IV access, NPO when ordered, pregnancy assessment, and communicating clinical urgency to radiology and transport teams.

Pre-test checks
Confirm patient identity, STAT PE indication, and that CTPA with IV contrast is the ordered protocol.
Review iodinated contrast allergy history — distinguish topical antiseptic reactions from true IV contrast reactions.
Verify recent creatinine or eGFR when institutional policy requires renal screening before IV contrast.
Ensure patent IV access sized for contrast injection rate per radiology protocol.
Document baseline SpO₂, heart rate, blood pressure, and symptom severity before transport.
Screen pregnancy status when radiation protection policy applies; coordinate monitored transport with oxygen and emergency equipment.
Medications to Review or Hold

Review anticoagulants, antiplatelets, metformin, and nephrotoxic medicines per contrast and PE protocols. Never withhold prescribed anticoagulation without prescriber orders — clarify timing relative to imaging and procedures.

Where the test is performed

This page is a Tests & Diagnostics guide for CT Pulmonary Angiography (CTPA). It emphasizes why the test is ordered, how to interpret results, when to escalate, and preparation factors that affect validity — not step-by-step performance technique (those live under Nursing Procedures when available).

CT Pulmonary Angiography (CTPA) is performed in the radiology or emergency imaging department with IV iodinated contrast and breath-hold CT acquisition. Ward and emergency nurses focus on PE indication verification, contrast allergy and renal screening, pregnancy assessment, IV access, safe transport, monitoring during and after contrast, and urgent action on positive PE reports or clinical deterioration — not scanner operation.

Use the preparation, results, and nursing responsibility sections below for safety checks, interpretation, escalation, and documentation — not equipment operation or departmental imaging protocols.

Result follow-up at a glance

Nursing workflow on this page — from order to safe action on results:

1
Confirm indication & correct order
2
Coordinate with laboratory or radiology per local policy
3
Document pre-analytic preparation & timing
4
Review result with trend & clinical picture
5
Escalate critical or discordant findings
6
Document communication & patient teaching

Results and Interpretation

CTPA results are descriptive radiology interpretations — not numeric laboratory values. Nurses integrate the report with symptoms, SpO₂ trends, hemodynamics, D-dimer context, and pre-test probability.

Reference Range Disclaimer

Reference ranges, critical values, and protocols may vary by laboratory, institution, patient population, and testing method. Always follow local policy and the reporting laboratory’s reference range.

Result Range / Finding Clinical Meaning Nursing Action
No acute critical finding / as expected for indication No pulmonary embolism identified (report wording varies by site) May support excluding PE when clinical probability was low — must fit the full picture Continue monitoring; escalate if dyspnea, SpO₂, or hemodynamics worsen despite negative wording
Equivocal / indeterminate finding Equivocal, limited, or technically suboptimal study May need repeat imaging, V/Q scan, leg ultrasound, or serial assessment per protocol Communicate limitations to prescriber; do not assume PE is excluded when suspicion remains high
Abnormal finding — clinically significant Filling defects or emboli reported in pulmonary arteries (segmental or larger) Often prompts anticoagulation, ICU monitoring, and evaluation for massive PE or right-heart strain Escalate urgent findings per policy; implement ordered anticoagulation and repeat assessment
Not applicable Not applicable for CTPA interpretation Not applicable — reports describe emboli and technical quality rather than high/low numeric values Interpret using the formal radiology report, clinical probability, and trends
↔ On a small screen, swipe or scroll sideways to see the full table.

Urgent PE Findings and Escalation

Imaging does not use laboratory critical values, but certain CTPA findings and paired clinical signs require immediate action.

Critical Finding Threshold / Value Immediate Action
Massive or central pulmonary embolism Reported central clot burden with hypotension, syncope, or severe hypoxemia Escalate urgently per facility PE protocol; support ordered oxygen, anticoagulation, and advanced therapy pathways per prescriber
Positive PE with worsening oxygenation Preliminary emboli reported with falling SpO₂ or increasing work of breathing Notify prescriber/rapid response; titrate oxygen; prepare for anticoagulation and ICU transfer per orders
Suspected contrast anaphylaxis Airway swelling, wheeze, hypotension, or respiratory distress during or after contrast Initiate emergency response per facility protocol; do not send patient back to ward without treatment plan
↔ On a small screen, swipe or scroll sideways to see the full table.
Stop and Escalate

Stop routine workflow and escalate according to facility policy when the patient develops severe respiratory distress, marked hypoxemia, hemodynamic instability, suspected contrast anaphylaxis, or when urgent CTPA findings conflict with rapid clinical deterioration.

Factors Affecting Results

CTPA interpretation can be affected by timing, technique, anticoagulation, and clinical probability relative to symptoms.

False Positives
  • Motion artifact or suboptimal opacification mimicking filling defects on technically limited scans
  • Pulmonary artery catheter or flow artifact misread as embolus on preliminary reads
  • Chronic organized thrombus versus acute embolus — formal radiology correlation required
False Negatives
  • Small subsegmental emboli missed on technically limited or early-phase studies
  • PE present despite negative CTPA when clinical probability remains high — per guideline pathways
  • Anticoagulation started before scan may alter clot appearance — document medicine timing
Interfering Factors
  • Inadequate contrast bolus timing or patient motion during breath-hold
  • Obesity, tachypnea, or inability to suspend respiration adequately
  • Timing relative to symptom onset and prior anticoagulation
Test Limitations

CTPA does not evaluate deep venous thrombosis of the legs unless separate imaging is ordered. Radiation and iodinated contrast carry distinct risks. A negative scan in a high-probability patient may still require further testing or serial assessment per ESC and national clinical guidelines VTE guidance — Turnaround and screening rules vary by institution; follow local institutional policy as a single universal cutoff for all settings.

Nursing Responsibilities

Nursing care centers on contrast safety screening, monitored transport, post-contrast surveillance, timely preliminary read communication, and integrating results with PE pathways.

Before the Test
Review PE indication, D-dimer, anticoagulant use, and urgency of CTPA order
Complete contrast allergy, pregnancy, and renal screening per policy
Document baseline SpO₂, vitals, and lung sounds; confirm IV access
Coordinate monitored transport with oxygen and emergency supplies
During the Test
Support breath-hold coaching and monitor for contrast reactions during injection
Maintain oxygen device and line patency during scan
Observe for anxiety, hypoxemia, or pain that may limit cooperation
After the Test
Record completion time, contrast lot if required, and immediate tolerance
Track preliminary and formal reads; communicate positive PE findings urgently
Trend SpO₂ and hemodynamics after anticoagulation or negative scans
Reinforce symptom reporting and leg swelling checks before discharge

Documentation

Clear documentation supports PE pathway handoffs when preliminary reads arrive before formal reports.

Example Nursing Note

“STAT CTPA completed 0315. Two identifiers verified. Contrast allergy history clarified (topical iodine only). Creatinine from 8 months ago — prescriber and radiology notified per protocol before contrast. Pre-transport SpO₂ 91% on 4 L/min; post-scan 89% with increased work of breathing. Preliminary read 0328: bilateral segmental pulmonary emboli. Prescriber notified with read-back; heparin infusion initiated per order. Formal report pending.”

Key Documentation Points
  • Indication, contrast screening, pregnancy and renal review, and transport time
  • IV access, contrast administration tolerance, and any reaction treated
  • Baseline and post-study SpO₂ with oxygen device and flow
  • Preliminary and formal read communication with read-back if required
  • Anticoagulation orders, bleeding precautions, and escalation calls
  • Patient teaching on PE symptoms, leg swelling, and follow-up imaging or labs

Patient and Family Education

Use plain language about breath-holding, IV contrast sensations, radiation, and symptoms that require immediate reporting.

Explain CTPA looks for blood clots in lung arteries using IV contrast and a brief scan
Describe warm flush or metallic taste with contrast as common sensations per RadiologyInfo
Review allergy and kidney history questions before the study
Clarify results may be preliminary first and finalized later by a radiologist
Teach patients to report sudden worsening breathlessness, chest pain, dizziness, or leg swelling
Explain anticoagulation and follow-up tests may be needed even if the first scan is negative when symptoms persist
📚

CT Pulmonary Angiography (CTPA) NCLEX practice questions

Practice NCLEX-style clinical judgment focused on CT Pulmonary Angiography (CTPA) safety and nursing judgment. Use the case tabs (orders, results, assessment, nursing notes), then answer eight Next Gen–style items (including an ordered workflow step) and evaluate outcomes with the answer key.

Select a tab to view orders, results, assessment, and nursing note details for this case.

  • Order: CT pulmonary angiography (CTPA) — STAT with IV contrast
  • Indication: Sudden pleuritic chest pain and dyspnea; suspected pulmonary embolism; D-dimer elevated
  • Timing: Ordered after bedside assessment and chest radiograph; anticoagulation not yet started
  • Related orders: D-dimer elevated; BMP/creatinine on chart from 8 months ago; leg ultrasound pending; oxygen titration per protocol
Question 1 — Priority action

After reviewing the case tabs, what is the nurse’s priority action before the patient leaves the unit for STAT CTPA?

Question 2 — Recognize cues

Which findings from the case tabs should prompt the nurse to clarify or escalate? Select all that apply. Select all that apply

Question 3 — Trend interpretation

Which trends are most concerning while CTPA is pending? Select all that apply.

Trend snapshot
SpO₂ 94% on 2 L/min at 2200 → 88% on 4 L/min at 2330; RR rising

Select all that apply

Question 4 — Matrix judgment

Classify each finding or action for this patient:

Finding Expected — document and continue monitoring Requires follow-up — notify team / repeat test Urgent — immediate escalation
Preliminary negative CTPA with high clinical suspicion and falling SpO₂ on current oxygen
Mild warmth during IV contrast injection without other symptoms
Preliminary bilateral pulmonary emboli with SpO₂ 86% and tachycardia
Patient taught to report worsening breathlessness and leg swelling before discharge

On a small screen, swipe or scroll sideways to see the full table.

Question 5 — Clinical judgment

The prescriber asks whether a negative CTPA rules out pulmonary embolism in this patient with rising clinical suspicion and falling SpO₂. Which response best reflects safe nursing practice?

Question 6 — Documentation (cloze)

Complete the priority documentation phrase after STAT CTPA for suspected PE:

After STAT CTPA for suspected pulmonary embolism, priority documentation includes .

Question 7 — Workflow (ordered response)

Before STAT CTPA for suspected pulmonary embolism, rank the nurse’s actions (1 = first).

  1. Verify two identifiers, PE indication, and that IV contrast is ordered with allergy and renal screening per protocol
  2. Document pregnancy status when relevant and anticoagulant use before transport
  3. Confirm patent IV access and communicate baseline SpO₂, heart rate, and symptom severity to radiology
  4. Reassess the patient, verify the order and identity, and prepare for prescriber follow-up
Question 8 — Evaluate outcomes

CTPA is complete. Preliminary read reports bilateral pulmonary emboli, but the patient now has SpO₂ 86% on prior oxygen and reports worsening pleuritic pain. What is the best nursing action?

Answer key & rationale

Frequently Asked Questions

FAQ

When is CTPA ordered instead of a V/Q scan?

CTPA is commonly selected when clinical probability and institutional pathways favor direct pulmonary artery imaging with IV contrast. V/Q scanning or ultrasound may be preferred when contrast is contraindicated or pregnancy concerns dominate — per ACR Appropriateness Criteria and local PE protocols. Turnaround and screening rules vary by institution; follow local institutional policy as a single universal rule for all patients.

Does the patient need to fast before CTPA?

NPO for several hours may be required when IV iodinated contrast is used — follow the radiology order and NHS CT patient information. Non-contrast studies are not standard for pulmonary angiography protocols.

What contrast reactions should nurses watch for after CTPA?

Monitor for urticaria, pruritus, wheeze, throat tightness, lip or tongue swelling, hypotension, and respiratory distress during and after iodinated contrast. Mild warmth or metallic taste can be common. Escalate according to facility protocol for suspected anaphylaxis or severe reactions per radiology guidelines Manual on Contrast Media principles.

When should renal function be reviewed before CTPA?

Review kidney function per institutional protocol when IV iodinated contrast is ordered, especially in patients with kidney disease, diabetes, or hypertension. radiology guidelines/NKF guidance emphasizes individualized risk assessment — necessary studies should not be delayed inappropriately, but outdated labs should be clarified.

Can pregnant patients have CTPA?

When PE is suspected, necessary imaging should not be withheld if benefits outweigh risks — ultrasound or V/Q alternatives may be considered when clinically appropriate. Pregnancy status should always be assessed and documented with radiation protection per institutional policy.

Can a negative CTPA rule out pulmonary embolism?

A negative CTPA often excludes PE when clinical probability was low to moderate and the study is technically adequate — but high-probability pathways may require further testing or serial assessment per ESC and national clinical guidelines VTE guidance. Continue monitoring if symptoms worsen.

How quickly are CTPA results available?

Many urgent PE protocols receive preliminary communication the same shift, but formal report timing varies by site and acuity. Turnaround and screening rules vary by institution; follow local policy.

References

References
  1. Radiological Society of North America. CT Angiography. RadiologyInfo.org.
    https://www.radiologyinfo.org/en/info/angiocath
  2. National Health Service. CT scan. NHS.uk; last reviewed November 2023.
    https://www.nhs.uk/conditions/ct-scan/
  3. American College of Radiology. ACR Appropriateness Criteria. ACR.
    https://www.acr.org/Clinical-Resources/Clinical-Tools-and-Reference/Appropriateness-Criteria
  4. American College of Radiology. ACR Manual on Contrast Media. ACR.
    https://www.acr.org/Clinical-Resources/Contrast-Manual
  5. American College of Radiology; National Kidney Foundation. ACR–NKF contrast administration in kidney disease.
    https://www.kidney.org/professionals/guidelines/contrast-induced-nephropathy-ckd
  6. Konstantinides SV et al.; ESC Scientific Document Group. 2019 ESC Guidelines for the diagnosis and management of acute pulmonary embolism. Eur Heart J.
    https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Acute-Pulmonary-Embolism-Diagnosis-and-Management-of
  7. National Institute for Health and Care Excellence. Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (NG158). NICE.
    https://www.nice.org.uk/guidance/ng158
  8. U.S. National Library of Medicine. CT scans. MedlinePlus.
    https://medlineplus.gov/ctscans.html

Editorial Standards & Medical Review

About the author: Sid A. Abdala Balal, RN, writes evidence-based nursing education focused on diagnostic safety, clinical interpretation, and bedside nursing judgment.

Medical review: This guide is reviewed by Dr. Adam Sayedi, MD, for clinical accuracy, diagnostic safety, and alignment with current standards for CT Pulmonary Angiography (CTPA).

Policies: Medical Review Process · Editorial Policy · Correction Policy